pravastatin has been researched along with Psychoses in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borba, CP; Cather, C; Cleary, SM; Copeland, PM; Fan, X; Freudenreich, O; Henderson, DC; Oppenheim, CE; Petruzzi, LJ; Stock, S; Vincenzi, B | 1 |
| Dimitri, E; Landry, P; Légaré, N; Tessier, S | 1 |
1 trial(s) available for pravastatin and Psychoses
| Article | Year |
|---|---|
A randomized placebo-controlled pilot study of pravastatin as an adjunctive therapy in schizophrenia patients: effect on inflammation, psychopathology, cognition and lipid metabolism.
Topics: Adult; Anticholesteremic Agents; Cognition Disorders; Drug Synergism; Female; Humans; Inflammation; Lipid Metabolism; Male; Middle Aged; Pilot Projects; Pravastatin; Psychotic Disorders; Schizophrenia; Treatment Outcome | 2014 |
1 other study(ies) available for pravastatin and Psychoses
| Article | Year |
|---|---|
Efficacy of lipid-lowering medications in patients treated with clozapine: a naturalistic study.
Topics: Adult; Antipsychotic Agents; Atorvastatin; Cholesterol; Clozapine; Female; Fenofibrate; Gemfibrozil; Heptanoic Acids; Humans; Hyperlipidemias; Hypolipidemic Agents; Lovastatin; Male; Middle Aged; Pravastatin; Psychotic Disorders; Pyrroles; Retrospective Studies; Schizophrenia; Treatment Outcome; Triglycerides | 2008 |